These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2322579)

  • 1. Modification of the accessibility of ribosomal proteins after elongation factor 2 binding to rat liver ribosomes and during translocation.
    Marzouki A; Lavergne JP; Reboud JP; Reboud AM
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):238-44. PubMed ID: 2322579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of elongation factor 2 (EF-2) with guanine nucleotides and ribosomes. Binding of periodate-oxidized guanine nucleotides to EF-2.
    Nurten R; Bermek E
    Eur J Biochem; 1980 Feb; 103(3):551-5. PubMed ID: 6244163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the reactivity of three amino-acid residues in elongation factor 2 during its binding to ribosomes and translocation.
    Lavergne JP; Marzouki A; Reboud AM; Reboud JP
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):231-7. PubMed ID: 2322578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the ribosomal binding site for eukaryotic elongation factor 2 by chemical cross-linking.
    Nygård O; Nilsson L; Westermann P
    Biochim Biophys Acta; 1987 Dec; 910(3):245-53. PubMed ID: 3676324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The L7/L12 proteins change their conformation upon interaction of EF-G with ribosomes.
    Gudkov AT; Gongadze GM
    FEBS Lett; 1984 Oct; 176(1):32-6. PubMed ID: 6092137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of phosphorylated elongation factor EF-2 with nucleotides and ribosomes.
    Dumont-Miscopein A; Lavergne JP; Guillot D; Sontag B; Reboud JP
    FEBS Lett; 1994 Dec; 356(2-3):283-6. PubMed ID: 7805855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ribosomal binding site for eukaryotic elongation factor EF-2 contains 5 S ribosomal RNA.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1987 Jan; 908(1):46-53. PubMed ID: 3801485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the ribosomal properties required for formation of a GTPase active complex with the eukaryotic elongation factor 2.
    Nygård O; Nilsson L
    Eur J Biochem; 1989 Feb; 179(3):603-8. PubMed ID: 2537725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 on translocation.
    Montanaro L; Sperti S; Testoni G; Mattioli A
    Biochem J; 1976 Apr; 156(1):15-23. PubMed ID: 182140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of GDP to a ribosomal protein after elongation factor-2 dependent GTP hydrolysis.
    Lavergne JP; Reboud AM; Sontag B; Guillot D; Reboud JP
    Biochim Biophys Acta; 1992 Oct; 1132(3):284-9. PubMed ID: 1420308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G; Abraham AK; Vedeler A
    FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional studies of the interaction of the eukaryotic elongation factor EF-2 with GTP and ribosomes.
    Nilsson L; Nygård O
    Eur J Biochem; 1988 Jan; 171(1-2):293-9. PubMed ID: 3338467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional groups of elongation factor 2 involved in interactions with guanosine nucleotides and ribosomes.
    Nurten R; Aktar NB; Bermek E
    FEBS Lett; 1983 Apr; 154(2):391-4. PubMed ID: 6832378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel data on interactions of elongation factor Ts.
    Bubunenko MG; Kireeva ML; Gudkov AT
    Biochimie; 1992 May; 74(5):419-25. PubMed ID: 1637866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ef-Ts elongation factor interacts with elongation factor EF-Tu on ribosomes prior to the GTP hydrolysis stage].
    Bubunenko MG; Gudkov AT
    Mol Biol (Mosk); 1991; 25(1):172-6. PubMed ID: 1896033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity labelling of the eukaryotic elongation factor EF-2 with the guanosine nucleotide analogue 5'-p-fluorosulfonylbenzoylguanosine.
    Nilsson L; Nygård O
    Biochim Biophys Acta; 1984 May; 782(1):49-54. PubMed ID: 6722159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A; Sontag B; Lavergne JP; Vidonne C; Reboud JP; Reboud AM
    Biochimie; 1991; 73(7-8):1151-6. PubMed ID: 1742357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of the protein-synthesis elongation cycle in eukaryotes. Effect of ricin on the ribosomal interaction with elongation factors.
    Nilsson L; Nygård O
    Eur J Biochem; 1986 Nov; 161(1):111-7. PubMed ID: 3780730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced turnover of the elongation factor EF-1 X ribosome complex after treatment with the protein synthesis inhibitor II from barley seeds.
    Nilsson L; Asano K; Svensson B; Poulsen FM; Nygård O
    Biochim Biophys Acta; 1986 Oct; 868(1):62-70. PubMed ID: 3756169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.